Name | LSP4–2022 |
---|
Description | LSP4–2022 is a novel potent, selective, brain-penetrant mGluR4 agonist with EC50 of 0.11 uM in cell-based assays; displays >100-fold selectivity over mGlu7 and mGlu8 (IC50=11.6 and 29.2 uM), no activity at the group I and -II mGlu receptors (EC50>100 uM); inhibits neurotransmission in cerebellar slices from mice, and possesses antiparkinsonian properties in a haloperidol-induced catalepsy test. |
---|---|
References | References 1. Goudet C, et al. FASEB J. 2012 Apr;26(4):1682-93. 2. Vilar B, et al. J Neurosci. 2013 Nov 27;33(48):18951-65. 3. Podkowa K, et al. Neuropharmacology. 2015 Oct;97:338-45. View Related Products by Target mGluR |
Molecular Formula | C13H18NO8P |
---|---|
Molecular Weight | 347.26 |